Cosimo Durante
Overview
Explore the profile of Cosimo Durante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
4537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grani G, Stramazzo I, Locantore P, Virili C, Filardi T, Lecis C, et al.
Endocrine
. 2024 Dec;
87(3):1131-1140.
PMID: 39671149
Purpose: Although thyroid nodules are less common in the pediatric population, the risk of malignancy is higher than in adult patients. The aim of this study was to evaluate the...
2.
Verrienti A, Pecce V, Grani G, Del Gatto V, Barp S, Maranghi M, et al.
J Endocrinol Invest
. 2024 Sep;
48(3):619-631.
PMID: 39298113
Purpose: Papillary thyroid carcinoma (PTC) is the most common malignant thyroid neoplasm, accounting for approximately 85% of all follicular cell-derived thyroid nodules. This study aimed to assess the diagnostic potential...
3.
Cantisani V, Bojunga J, Durante C, Dolcetti V, Pacini P
Ultraschall Med
. 2024 Sep;
46(1):14-35.
PMID: 39242086
Thyroid nodules are common incidental findings. Most of them are benign, but many unnecessary fine-needle aspiration procedures, core biopsies, and even thyroidectomies or non-invasive treatments have been performed. To improve...
4.
Raffaelli M, Voloudakis N, Barczynski M, Brauckhoff K, Durante C, Gomez-Ramirez J, et al.
Br J Surg
. 2024 Aug;
111(8).
PMID: 39158073
No abstract available.
5.
Grani G, Sponziello M, Filetti S, Durante C
Nat Rev Endocrinol
. 2024 Aug;
20(12):715-728.
PMID: 39152228
Thyroid nodules, with a prevalence of almost 25% in the general population, are a common occurrence. Their prevalence varies considerably depending on demographics such as age and sex as well...
6.
Grani G, DElia S, Puxeddu E, Morelli S, Arvat E, Nervo A, et al.
J Clin Endocrinol Metab
. 2024 Aug;
PMID: 39150986
Context: The utility of thyroglobulin (Tg) in the follow-up of differentiated thyroid cancer (DTC) patients has been well-documented. Although third-generation immunoassays have improved accuracy, limitations persist (interfering anti-Tg antibodies and...
7.
Biffoni M, Grani G, Melcarne R, Geronzi V, Consorti F, Ruggieri G, et al.
J Clin Med
. 2024 Apr;
13(5).
PMID: 38592234
: Effective pre-surgical planning is crucial for achieving successful outcomes in endocrine surgery: it is essential to provide patients with a personalized plan to minimize operative and postoperative risks. Preoperative...
8.
Piticchio T, Russ G, Radzina M, Frasca F, Durante C, Trimboli P
Eur Thyroid J
. 2024 Feb;
13(2).
PMID: 38417254
Context: Ultrasound-based risk stratification systems (Thyroid Imaging Reporting and Data Systems (TIRADSs)) of thyroid nodules (TNs) have been implemented in clinical practice worldwide based on their high performance. However, it...
9.
Pita J, Raspe E, Coulonval K, Decaussin-Petrucci M, Tarabichi M, Dom G, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1247542.
PMID: 37964967
Background: CDK4/6 inhibitors (CDK4/6i) have been established as standard treatment against advanced Estrogen Receptor-positive breast cancers. These drugs are being tested against several cancers, including in combinations with other therapies....
10.
Durante C, Hegedus L, Na D, Papini E, Sipos J, Baek J, et al.
Radiology
. 2023 Oct;
309(1):e231481.
PMID: 37906014
Multiple US-based systems for risk stratification of thyroid nodules are in use worldwide. Unfortunately, the malignancy probability assigned to a nodule varies, and terms and definitions are not consistent, leading...